Higher levels of PCSK9 are associated with cardiovascular events in patients with AF, possibly through atherosclerosis and inflammation.22 Peptidoglycan recognition protein 1 (PGLYRP1), a protein important in the innate immune response, was also associated with AF progression. Here, PCSK9 is linked to atherosclerosis.